Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
COR stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Cencora, Inc. stock logo

Cencora, Inc.

COR·NYSE

Huling na-update noong 2026-02-12 09:34 EST. Ang impormasyon sa presyo ng stock ay nagmumula sa TradingView at sumasalamin sa real-time market prices.

Insights
Calculator
News

COR stock price change

Sa huling araw ng trading, COR sarado ang stock sa 358.72 USD, na may pagbabago sa presyo ng -0.36% para sa araw.
Trade stock futures

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more

COR key data

Previous close358.72 USD
Market cap69.78B USD
Volume117.85K
P/E ratio43.15
Dividend yield (TTM)0.63%
Dividend amount0.60 USD
Last ex-dividend dateNov 14, 2025
Last payment dateDec 01, 2025
EPS diluted (TTM)8.31 USD
Net income (FY)1.55B USD
Revenue (FY)321.33B USD
Next report dateMay 6, 2026
EPS estimate4.880 USD
Revenue estimate81.42B USD USD
Shares float193.71M
Beta (1Y)−0.09
Tokenized stocks

Nakarinig ka na ba ng tungkol sa mga tokenized stock?

Isang bagong paraan ng trade stocks — anumang oras, kahit saan, 24/7.

Learn more

Cencora, Inc. overview

Ang Cencora, Inc. ay isang kumpanya ng pharmaceutical sourcing at distribution services. Ito ay nag-ooperate sa pamamagitan ng United States (U.S.) Healthcare Solutions at International Healthcare Solutions na mga segment. Ang U.S. Healthcare Solutions segment ay nagbibigay ng branded, specialty branded at generic na mga gamot, over-the-counter na mga produktong pangkalusugan, mga supply at kagamitan para sa home healthcare, at mga kaugnay na serbisyo sa iba’t ibang healthcare providers. Ang International Healthcare Solutions segment ay kinabibilangan ng mga negosyo na nakatuon sa international pharmaceutical wholesale at mga kaugnay na operasyon ng serbisyo, pati na rin sa global commercialization services. Itinatag ang kumpanya ni Emil P. Martini noong 1947 at ang punong-tanggapan nito ay nasa Conshohocken, PA.
Sector
Mga serbisyo sa pamamahagi
Industry
Mga tagapamahagi ng medikal na kagamitan
CEO
Robert P. Mauch
Headquarters
Conshohocken
Website
cencora.com
Founded
1947
Employees (FY)
51K
Change (1Y)
+5K +10.87%
Revenue / Employee (1Y)
6.30M USD
Net income / Employee (1Y)
30.47K USD

COR Pulse

Daily updates on COR stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• Presyo ng stock ng Cencora, Inc. (COR): 360.28 USD (pagbabago sa loob ng 24h: +0.08%). Kahapon (Pebrero 10, 2026), nagsara ang presyo sa 360.00 USD, bumaba ng 0.90% habang tinatanggap ng merkado ang mga kamakailang pagtaas at ang malaking anunsyo ng 3 bilyong USD na utang na inilabas huli ng araw.
• Mula sa teknikal na pananaw, nagpapakita ang COR ng "malakas na bullish consolidation" na profile. Ang stock ay kalakalan nang mas mataas kaysa sa 50-day (346.17 USD) at 200-day (327.39 USD) moving averages, na may Relative Strength Index (RSI) na malapit sa 68.7, na nagpapahiwatig ng matinding momentum na papalapit sa overbought territory. Ang teknikal na suporta ay matatag sa antas na 358 USD, habang ang resistance ay nananatili malapit sa 52-week high na 377.54 USD.
• Inanunsyo ng Cencora ang pagpepresyo ng 3.0 bilyong USD sa senior notes sa limang tranches (maturing 2029-2056) upang pondohan ang pagkuha ng OneOncology at bayaran ang kasalukuyang utang.
• Ilang analyst sa Wall Street, kabilang ang JPMorgan at Wells Fargo, ay nagtaas ng kanilang mga target na presyo para sa COR sa hanay na 419-429 USD, na binanggit ang malakas na demand para sa specialty medicines at GLP-1 therapies kasunod ng Q1 earnings beat.
• Magte-trade ang COR ex-dividend sa Pebrero 13, 2026, para sa nalalapit nitong 0.60 USD kada share na quarterly payment, na nag-aambag sa bahagyang panandaliang pagbabago ng presyo.
• Nagsagawa ang U.S. House Subcommittee on Health ng pagdinig noong Pebrero 11, 2026, upang suriin ang supply chain ng mga reseta ng gamot at mga potensyal na reporma na naglalayong sa transparency ng distribusyon at mga pharmacy benefit manager (PBMs).
• Inilunsad ng administrasyon ang TrumpRx.gov noong Pebrero 5, 2026, isang bagong platform na idinisenyo upang mag-alok ng "most-favored nation" pricing at mga coupon para sa mga pasyenteng nagbabayad ng cash, na nagpapahiwatig ng patuloy na presyur sa pulitika sa gastos ng gamot.
See more
about 22h ago
• Pagbabago sa presyo ng COR stock sa loob ng 24h: -1.00%. Mula 363.27 USD pababa sa 359.65 USD.
• Sa teknikal na pananaw, nagpapakita ang stock ng "matatag na konsolidasyon" matapos ang kamakailang volatility ng earnings. Bagaman bahagyang umatras kahapon, nananatili itong 3.63% sa ibabaw ng 50-day moving average ($345.98) at malayo sa 200-day average ($326.90). Ang RSI na 55 ay nagpapahiwatig ng neutral-to-bullish momentum, na nagpapakita na tinatanggap ng merkado ang mga kamakailang kita kasunod ng Q1 fiscal 2026 earnings beat.
• Naglabas ang Cencora ng maraming serye ng senior unsecured notes noong Pebrero 10, 2026 upang i-refinance ang $3.0 bilyong short-term loan na ginamit para sa $4.6 bilyong acquisition ng OneOncology, na nag-optimize sa istruktura ng pangmatagalang utang nito.
• Noong Pebrero 9, bumawi ang stock ng Cencora ng 1.12% sa regular trading, na nilampasan ang paunang pagbaba sa pre-market na dulot ng revenue na hindi umabot sa inaasahan ng analyst kahit na nag-beat sa earnings per share (EPS).
• Kamakailan ay nagdeklara ang Cencora ng quarterly dividend na $0.60 bawat share, na may ex-dividend date sa Pebrero 13, 2026 at nakatakdang bayaran sa Marso 2, na nagpapakita ng dedikasyon nito sa pagbabalik sa mga shareholder.
• Tinapos ng gobyerno ng U.S. ang Consolidated Appropriations Act para sa fiscal year 2026 noong Pebrero 3, na kinabibilangan ng malalaking reporma sa Pharmacy Benefit Manager (PBM) at pagpapalawig ng pondo para sa mga pangunahing health program, na may epekto sa mas malawak na healthcare distribution landscape.
• Ang pinakabagong CMS data na inilabas noong unang bahagi ng Pebrero ay nagpapakita na ang enrollment sa 2026 ACA Marketplace ay bumaba ng 5% taon-taon, na nagpapahiwatig ng pagbabago sa mga trend ng paggamit ng healthcare habang nag-e-expire ang mga enhanced tax credits.
See more
about 1D ago

COR stock price forecast

According to technical indicators for COR stock, the price is likely to fluctuate within the range of 390.16–425.29 USD over the next week. Market analysts predict that the price of COR stock will likely fluctuate within the range of 350.74–433.41 USD over the next months.

Based on 1-year price forecasts from 89 analysts, the highest estimate is 1086.43 USD, while the lowest estimate is 377.61 USD.

For more information, please see the COR stock price forecast Stock Price Forecast page.

Sa isang Bitget account lang, maaari kang mag-trade ng mga stock at cryptocurrencies nang sabay.

Join now!

FAQ

What is the stock price of Cencora, Inc.?

COR ay kasalukuyang nakapresyo sa 358.72 USD — ang presyo nito ay nagbago ng -0.36% sa nakalipas na 24 na oras. Maaari mong subaybayan ang pagganap ng presyo ng stock ng Cencora, Inc. mas malapit sa chart ng presyo sa tuktok ng pahinang ito.

What is the stock ticker of Cencora, Inc.?

Depende sa exchange, maaaring mag-iba ang stock ticker. Halimbawa, sa NYSE, Cencora, Inc. ay tini-trade sa ilalim ng ticker COR.

What is the stock forecast of COR?

Nagtipon kami ng mga opinyon ng mga analyst tungkol sa Cencora, Inc.future price. Ayon sa kanilang mga pagtataya, COR ay may pinakamataas na pagtatantya ng 3587.20 USD at isang minimum na pagtatantya ng 717.44 USD.

What is the market cap of Cencora, Inc.?

Cencora, Inc. ay may market capitalization ng 69.78B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official " Fee overview " or " Announcement Center " page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
COR